We are live on
!
Find out more
GC
Guggenheim Capital Portfolio holdings
AUM
$12.9B
1-Year Est. Return
27.3%
This Fund
S&P 500
This Quarter
Est. Return
+4.47%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$15B
AUM Growth
-$26B
(-63%)
Cap. Flow
-$26.2B
Cap. Flow
% of AUM
-175.02%
Top 10 Holdings %
Top 10 Hldgs %
16.62%
Holding
2,824
New
59
Increased
423
Reduced
1,872
Closed
463
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$24.9M |
| 2 |
Viatris
VTRS
|
+$22.8M |
| 3 |
Accenture
ACN
|
+$17.8M |
| 4 |
Seagate
STX
|
+$14.1M |
| 5 |
SHPG
Shire pic
SHPG
|
+$11.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$141M |
| 2 |
Meta Platforms (Facebook)
META
|
+$109M |
| 3 |
Adobe
ADBE
|
+$107M |
| 4 |
PayPal
PYPL
|
+$107M |
| 5 |
NVIDIA
NVDA
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.52% |
| 2 | Healthcare | 10.18% |
| 3 | Financials | 9.9% |
| 4 | Consumer Discretionary | 8.09% |
| 5 | Industrials | 7.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABMD
76
DELISTED
Abiomed Inc
ABMD
| $28M | 0.19% |
68,562
-54,108
| -44% | -$19.6M |
|
77
OGE Energy
OGE
$9.87B
| $27.9M | 0.19% |
793,351
-64,807
| -8% | -$2.18M |
|
78
McCormick & Company Non-Voting
MKC
$14B
| $27.9M | 0.19% |
480,490
-813,698
| -63% | -$42.7M |
|
79
Estee Lauder
EL
$30.4B
| $27.5M | 0.18% |
192,950
-473,673
| -71% | -$70.1M |
|
80
TJX Companies
TJX
$179B
| $27.5M | 0.18% |
577,998
-700,904
| -55% | -$30.8M |
|
81
American Tower
AMT
$83.5B
| $27.4M | 0.18% |
189,851
-355,056
| -65% | -$49.3M |
|
82
Berkshire Hathaway Class B
BRK.B
$1.1T
| $27.2M | 0.18% |
145,888
-377,292
| -72% | -$73.5M |
|
83
S&P Global
SPGI
$124B
| $26.9M | 0.18% |
131,833
-271,905
| -67% | -$53.7M |
|
84
Alexandria Real Estate Equities
ARE
$9.37B
| $26.7M | 0.18% |
211,245
-267,159
| -56% | -$33.4M |
|
85
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.41B
| $25.8M | 0.17% |
487,288
+1,691
| +0.3% | +$89.2K |
|
86
Wells Fargo
WFC
$254B
| $25.7M | 0.17% |
463,181
-991,875
| -68% | -$53.1M |
|
87
Citigroup
C
$213B
| $25.7M | 0.17% |
383,623
-767,052
| -67% | -$52.8M |
|
88
Mondelez International
MDLZ
$82.9B
| $25.6M | 0.17% |
624,747
-989,907
| -61% | -$39.8M |
|
89
Regeneron Pharmaceuticals
REGN
$72.9B
| $25.5M | 0.17% |
73,938
-145,747
| -66% | -$45.6M |
|
90
Lam Research
LRCX
$316B
| $25.3M | 0.17% |
1,465,990
-4,287,380
| -75% | -$82.6M |
|
91
Automatic Data Processing
ADP
$109B
| $25.3M | 0.17% |
188,802
-452,354
| -71% | -$57.3M |
|
92
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.05B
| $25.2M | 0.17% |
236,722
-28,242
| -11% | -$3.03M |
|
|
GBAB
93
Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust
GBAB
$380M
| $25M | 0.17% |
1,154,388
-23,500
| -2% | -$503K |
|
94
Oracle
ORCL
$339B
| $25M | 0.17% |
566,817
-1,162,803
| -67% | -$53.6M |
|
|
95
LyondellBasell Industries
LYB
$19.5B
| $24.9M | 0.17% |
+226,660
| New | +$24.9M |
|
96
Ameren
AEE
$30.4B
| $24.9M | 0.17% |
409,129
-726,302
| -64% | -$41.7M |
|
97
Medtronic
MDT
$112B
| $24.9M | 0.17% |
290,272
-572,744
| -66% | -$47.8M |
|
98
Oneok
OKE
$56.7B
| $24.8M | 0.17% |
355,488
-709,321
| -67% | -$45.7M |
|
99
Illinois Tool Works
ITW
$84.1B
| $24.5M | 0.16% |
176,592
-268,871
| -60% | -$39.8M |
|
|
ESRX
100
DELISTED
Express Scripts Holding Company
ESRX
| $24.4M | 0.16% |
316,621
-699,626
| -69% | -$52.5M |
|
Similar funds
TRSOTSOK
AIM
CII
AAMU
NMIFOAC
WANY
ACA
Guggenheim Capital's Q2 2018 Portfolio in Review
As of Q2 2018, Guggenheim Capital held 2,824 positions worth $15B, down 63% from $41B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Guggenheim Capital withdrew a net $26.2B in Q2 2018, closing 463 positions and reducing 1,872 holdings. Its most notable exit was CSRA Inc., an estimated $64.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Guggenheim Capital opened a new position in LyondellBasell Industries worth $24.9M.
- Guggenheim Capital's largest Q2 2018 buy was LyondellBasell Industries: 226,660 shares worth $24.9M.
- Guggenheim Capital added most to Shire pic in Q2 2018, an estimated $11.5M increase.
- Guggenheim Capital's biggest Q2 2018 reduction was Apple, cutting an estimated $141M.
- Guggenheim Capital fully exited CSRA Inc. in Q2 2018, selling an estimated $64.7M.
- Guggenheim Capital's ten largest holdings make up 17% of its $15B portfolio in Q2 2018.
- Guggenheim Capital opened 59 new positions and closed 463 in Q2 2018.
- Guggenheim Capital's portfolio value fell 63% quarter-over-quarter to $15B.
Based on Guggenheim Capital's 13F filing for Q2 2018, filed 14 Aug 2018.